Innovation sourcing in biopharma: Four practices to maximize success | McKinsey
Ons team - Berghauser Pont
Lotte Stapper - zonder achtergrond - Berghauser Pont Academy : Berghauser Pont Academy
Developing blockbuster drugs: both nature and nurture
The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells | PLOS ONE
Lotte M E Berghauser Pont's research works | Erasmus MC, Rotterdam (Erasmus MC) and other places
Lotte Stapper - Programmamanager - Berghauser Pont Mediagroep | LinkedIn
Lotte M E Berghauser Pont's research works | Erasmus MC, Rotterdam (Erasmus MC) and other places
GRANDPRIX TV - LOTTE BERGHAUSER PONT
Ons team - Berghauser Pont
GRANDPRIX TV - LOTTE BERGHAUSER PONT
Developing blockbuster drugs: both nature and nurture
Innovation sourcing in biopharma: Four practices to maximize success | McKinsey
Lotte | McKinsey & Company
Self-learning: The dawn of a new biomedical R&D paradigm | McKinsey
The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells | PLOS ONE
Lotte Geense - Berghauser Pont Academy : Berghauser Pont Academy
Lotte M E Berghauser Pont's research works | Erasmus MC, Rotterdam (Erasmus MC) and other places
RePub, Erasmus University Repository: Combination therapies in a patient-derived glioblastoma model
Lotte Stapper - Programmamanager - Berghauser Pont Mediagroep | LinkedIn
